Page 1 of 3 AC6302/004 February 26, 2020 Subject Clarification of the operating results for the year end ended December 31, 2019 To Director/ Managing Director The Stock Exchange of Thailand
Page 1 of 2 SET 007/2020 12 August 2020 Subject Management Discussion and Analysis for the second quarter 2020 To The President of the Stock Exchange of Thailand The Company would like to provide
1/2 (Translation) Ref. HPIR 004/2018 February 28, 2018 Subject : Management Discussion and Analysis for the year ended December 31, 2017 To : The President The Stock Exchange of Thailand Duplicate
Ref. PDI/BK-BS-011/2019 25th February 2019 Re: Management Discussion and Analysis (MD&A) For the year ended December 31, 2018 To: President The Stock Exchange of Thailand Due to depletion of Mae Sod
26 February 2019 Subject: Management Discussion and Analysis for the Year Ended December 31, 2018 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company Limited
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
Microsoft Word - 2017_Q2 Results Notification letter_English August 8, 2017 The Director and Manager The Stock Exchange of Thailand Re: Information on Second Quarter of 2017 Operating Results KCE
-9320 1 Ref: PLC 2017/017 November 16, 2017 Subject: Management Discussion and Analysis Quarter 3 Ended 30-September-2017 (Additional) To: The President of the Stock Exchange of Thailand Panjawattana
26 February 2018 Subject: Management Discussion and Analysis for the Year Ended December 31, 2017 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company Limited